Crystalline polymorph forms of 2-(5-bromo-4-(4-cyclopropyl naphthalen-l-yl)-4H-l,2,4-triazol- 3-ylthio)acetic acid are described. Pharmaceutical compositions and the uses of such compounds, compound forms, and compositions for the treatment of a variety of diseases and conditions are also presented.